Contribution of gut microbiota to drug-induced liver injury

被引:15
|
作者
Chu, Hui-Kuan [1 ]
Ai, Yan [1 ]
Cheng, Zi-Lu [1 ]
Yang, Ling [1 ]
Hou, Xiao-Hua [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Div Gastroenterol, Wuhan 430022, Peoples R China
基金
中国国家自然科学基金;
关键词
Gut microbiota; Lipopolysaccharide; Probiotics; Fecal microbiota transplantation; Drug -induced Liver injury; SIGNAL-TRANSDUCTION PATHWAYS; AKKERMANSIA-MUCINIPHILA; INTESTINAL MICROBIOME; RECEPTOR; 4; ACETAMINOPHEN; MICE; PROTECTS; HEPATOTOXICITY; INFLAMMATION; ENDOTOXEMIA;
D O I
10.1016/j.hbpd.2023.06.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Drug-induced liver injury (DILI) is caused by various drugs with complex pathogenesis, and diverse clinical and pathological phenotypes. Drugs damage the liver directly through drug hepatotoxicity, or indirectly through drug-mediated oxidative stress, immune injury and inflammatory insult, which eventually lead to hepatocyte necrosis. Recent studies have found that the composition, relative content and distribution of gut microbiota in patients and animal models of DILI have changed significantly. It has been confirmed that gut microbial dysbiosis brings about intestinal barrier destruction and microorganisms translocation, and the alteration of microbial metabolites may cause or aggravate DILI. In addition, antibiotics, probiotics, and fecal microbiota transplantation are all emerging as prospective therapeutic methods for DILI by regulating the gut microbiota. In this review, we discussed how the altered gut microbiota participates in DILI.(c) 2023 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:458 / 465
页数:8
相关论文
共 50 条
  • [21] Drug-induced liver injury in children
    Amin, Mansi D.
    Harpavat, Sanjiv
    Leung, Daniel H.
    CURRENT OPINION IN PEDIATRICS, 2015, 27 (05) : 625 - 633
  • [22] Drug-induced liver injury in the elderly
    Stine J.G.
    Sateesh P.
    Lewis J.H.
    Current Gastroenterology Reports, 2013, 15 (1)
  • [23] Drug-induced liver injury in 2007
    Norris, William
    Paredes, Angelo H.
    Lewis, James H.
    CURRENT OPINION IN GASTROENTEROLOGY, 2008, 24 (03) : 287 - 297
  • [24] Biomarkers for drug-induced liver injury
    Shi, Qiang
    Hong, Huixiao
    Senior, John
    Tong, Weida
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (02) : 225 - 234
  • [25] Signatures in drug-induced liver injury
    Tillmann, Hans L.
    Rockey, Don C.
    CURRENT OPINION IN GASTROENTEROLOGY, 2020, 36 (03) : 199 - 205
  • [26] Chemical probes for drug-induced liver injury imaging
    Jiang, Tao
    Rong, Pengfei
    Wang, Wei
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (09) : 835 - 852
  • [27] Circulating mitochondrial biomarkers for drug-induced liver injury
    Shi, Qiang
    Yang, Xi
    Mattes, William B.
    Mendrick, Donna L.
    Harrill, Alison H.
    Beger, Richard D.
    BIOMARKERS IN MEDICINE, 2015, 9 (11) : 1215 - 1223
  • [28] Drug-induced Liver Injury Caused by Intravenously Administered Medications: The Drug-induced Liver Injury Network Experience
    Ghabril, Marwan
    Fontana, Robert
    Rockey, Don
    Jiezhun, Gu
    Chalasani, Naga
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (06) : 553 - 558
  • [29] The role of gut microbiota and metabolites in regulating the immune response in drug-induced enteritis
    Chen, Yuxuan
    Wang, Zhaojun
    Chen, Xinli
    Chao, Guanqun
    Zhang, Shuo
    JOURNAL OF APPLIED MICROBIOLOGY, 2023, 134 (03)
  • [30] Gut microbiota causally affects drug-induced liver injury via plasma metabolites: a Mendelian randomization study
    Fu, Haoshuang
    Zhao, Shuang
    Song, Shuying
    Xie, Qing
    FRONTIERS IN MICROBIOLOGY, 2024, 15